ESC 365 - Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Open Access

Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Session: Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Topic: Atrial fibrillation (AF)

Speaker: Professor R. Mehran (New York, US)

Sponsored by Bayer AG

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

54 presentations

12 followers

4 more presentations in this session

New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Speaker: Professor K. Fox (Edinburgh, GB)

Special considerations in the management of patients with AF undergoing ablation or cardioversion.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

How can we appropriately treat multimorbid patients with AF?

Speaker: Doctor C. Ruff (Boston, US)

Closing remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Doctor R. Cappato (Sesto San Giovanni, IT)

Access the full session

Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Speakers: Professor R. Mehran, Professor K. Fox, Professor S. Hohnloser, Doctor C. Ruff, Doctor R. Cappato

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources